‘Thunder Run’: Behind Lawmakers’ Secretive Push to Pass the TikTok Bill
Posted inBeijing Bytedance Technology Co Ltd Cantwell, Maria Computers and the Internet Gallagher, Mike (1984- ) House Committee on Energy and Commerce House of Representatives Justice Department Krishnamoorthi, Raja Law and Legislation Lobbying and Lobbyists McMorris Rodgers, Cathy Mergers, Acquisitions and Divestitures Mobile Applications Monaco, Lisa O National Security Council Propaganda Scalise, Steve Social Media United States International Relations United States Politics and Government

‘Thunder Run’: Behind Lawmakers’ Secretive Push to Pass the TikTok Bill

A tiny group of lawmakers huddled in private about a year ago, aiming to keep the discussions away from TikTok lobbyists while bulletproofing a bill that could ban the app.
What a TikTok Ban Would Mean for the U.S. Defense of an Open Internet
Posted inBeijing Bytedance Technology Co Ltd Censorship Computers and the Internet House of Representatives International Relations Law and Legislation Social Media TikTok (ByteDance) United States International Relations United States Politics and Government

What a TikTok Ban Would Mean for the U.S. Defense of an Open Internet

Global digital rights advocates are watching to see if Congress acts, worried that other countries could follow suit with app bans of their own.
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Posted inBiotechnology and Bioengineering Cancer China Cystic Fibrosis Delaware Drugs (Pharmaceuticals) Eli Lilly and Company Factories and Manufacturing GlaxoSmithKline PLC Government Contracts and Procurement House of Representatives Intellectual Property Janssen Pharmaceutica Labor and Jobs Leukemia Massachusetts People's Liberation Army (China) Research Senate Shortages Start-ups Supply Chain Tax Credits, Deductions and Exemptions United States International Relations United States Politics and Government

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.